SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-19-000053
Filing Date
2019-05-09
Accepted
2019-05-09 16:03:03
Documents
17
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201905098xkdoc.htm 8-K 34059
2 PRESS RELEASE pdli-201905098xkex991.htm EX-99.1 151645
3 PRESENTATION pdli-201905098xkex992.htm EX-99.2 5945
4 INFORMATION SHEET pdli-201905098xkex993.htm EX-99.3 92546
5 pdllogoa19.jpg GRAPHIC 123123
6 slide1a96.jpg GRAPHIC 46334
7 slide2a96.jpg GRAPHIC 199452
8 slide3a96.jpg GRAPHIC 133664
9 slide4a96.jpg GRAPHIC 133774
10 slide5a96.jpg GRAPHIC 87950
11 slide6a96.jpg GRAPHIC 112538
12 slide7a96.jpg GRAPHIC 142423
13 slide8a94.jpg GRAPHIC 129437
14 slide9a93.jpg GRAPHIC 134570
15 slidv45.jpg GRAPHIC 169379
16 slidv46.jpg GRAPHIC 121059
17 slidv47.jpg GRAPHIC 114659
  Complete submission text file 0000882104-19-000053.txt   2556519
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 19810409
SIC: 2836 Biological Products, (No Diagnostic Substances)